Yamashita U
Jpn J Cancer Res. 1985 Jun;76(6):532-40.
The effect of teleocidin, a new tumor promoter, on immune responses was studied in vitro using murine lymphocytes. Teleocidin had a mitogenic and a comitogenic activity on murine lymphocytes at doses of 1-1000 ng/ml. The responder cells to teleocidin stimulation were T cells. However, for the stimulation of T cells with teleocidin, Ia-positive macrophages were required as accessory cells. On the other hand, teleocidin had a suppressive activity at the same doses on the induction of hapten-reactive cytotoxic T cell response in vitro. All these results on mitogenic and immunosuppressive activity are similar to those obtained in a previous study on 12-O-tetradecanoyl phorbol-13-acetate. Thus, it is suggested that the role of tumor promoters during carcinogenesis is a potentiation of the growth of transformed cells and a suppression of the immune-surveillance mechanism.
使用鼠淋巴细胞在体外研究了一种新型肿瘤促进剂——远藤菌素对免疫反应的影响。远藤菌素在1-1000 ng/ml的剂量下对鼠淋巴细胞具有促有丝分裂和协同有丝分裂活性。对远藤菌素刺激有反应的细胞是T细胞。然而,要用远藤菌素刺激T细胞,需要Ia阳性巨噬细胞作为辅助细胞。另一方面,远藤菌素在相同剂量下对体外半抗原反应性细胞毒性T细胞反应的诱导具有抑制活性。所有这些关于促有丝分裂和免疫抑制活性的结果与先前关于12-O-十四酰佛波醇-13-乙酸酯的研究结果相似。因此,有人提出肿瘤促进剂在致癌过程中的作用是增强转化细胞的生长并抑制免疫监视机制。